IPTORZA Trademark

Trademark Overview

On Wednesday, July 31, 2013, a trademark application was filed for IPTORZA with the United States Patent and Trademark Office. The USPTO has given the IPTORZA trademark a serial number of 86024967. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2017. This trademark is owned by Glaxo Group Limited. The IPTORZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
iptorza

General Information

Serial Number86024967
Word MarkIPTORZA
Filing DateWednesday, July 31, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "IPTORZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 29, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2016EXTENSION 5 GRANTED
Monday, September 12, 2016EXTENSION 5 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Tuesday, March 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 26, 2016EXTENSION 4 GRANTED
Wednesday, March 16, 2016EXTENSION 4 FILED
Wednesday, March 16, 2016TEAS EXTENSION RECEIVED
Tuesday, September 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2015EXTENSION 3 GRANTED
Tuesday, September 8, 2015EXTENSION 3 FILED
Tuesday, September 8, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2015EXTENSION 2 GRANTED
Tuesday, March 31, 2015EXTENSION 2 FILED
Thursday, May 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 30, 2014EXTENSION 1 GRANTED
Tuesday, September 30, 2014EXTENSION 1 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 17, 2014ASSIGNED TO LIE
Wednesday, December 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2013EXAMINER'S AMENDMENT ENTERED
Wednesday, December 18, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 18, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, December 18, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 12, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2013NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2013NON-FINAL ACTION WRITTEN
Friday, November 8, 2013ASSIGNED TO EXAMINER
Wednesday, August 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 3, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

iptorza pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological